MedTrace Logo

Nutritional Therapy Study in Pediatric Crohn's Disease

NCT02610101 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2019-05-24

No results posted yet for this study

Summary

The investigators are doing this research study to answer questions about a nutritional therapy called the Specific Carbohydrate Diet (SCD) for children with active Crohn's Disease (CD). The SCDiet is a diet where all grains such as wheat, barley, corn, rice are restricted. Most dairy products (except certain yogurt) are also restricted. The diet mainly consists of meat, fruits, vegetables, nuts, oils and honey, and is offered to individuals with active Crohn's disease as part of standard of care at Seattle Children's.

For this study, the investigators will have three different dietary groups:

1. Traditional SCD diet group
2. Modified SCD to include oatmeal and rice
3. SCD with whole foods without added sugar

Specifically, the investigators want to know:

* Is the SCD well tolerated?
* Is SCD effective for the treatment for active Crohn's Disease?
* Will the results from the varied three dietary groups have the same results for each patient?

Conditions

Interventions

OTHER

Traditional SCD Diet

Traditional SCD includes removal of all processed foods as well as all grains, sweetners except for honey and all diary except for yogurt fermented for over 24hrs and some hard cheeses

OTHER

Modified SCD Diet

Food components of the traditional SCD with the addition of rice and oats.

OTHER

Whole foods diet

A whole foods diet with removal of processed foods. Removal of corn, wheat, sugar and milk are also apart of this dietary regime.

Sponsors & Collaborators

  • Seattle Children's Hospital

    lead OTHER

Principal Investigators

  • David L Suskind, MD · Seattle Children's Hospital and The University of Washington

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
FACTORIAL

Eligibility

Min Age
12 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02610101 on ClinicalTrials.gov